- Home
- REPL vs HBNC Comparison
REPL vs HBNC Comparison
Compare REPL & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REPL | HBNC |
|---|---|---|
| Founded | 2015 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.3M | 883.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | REPL | HBNC |
|---|---|---|
| Price | $7.24 | $18.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $12.00 | ★ $19.67 |
| AVG Volume (30 Days) | ★ 1.4M | 387.6K |
| Earning Date | 02-11-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $51.78 |
| Revenue Next Year | N/A | $7.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $2.68 | $12.70 |
| 52 Week High | $14.80 | $18.70 |
Technical Indicators
Market Signals| Indicator | REPL | HBNC |
|---|---|---|
| Relative Strength Index (RSI) | 28.73 | 63.98 |
| Support Level | $6.77 | $17.14 |
| Resistance Level | $9.41 | $17.78 |
| Average True Range (ATR) | 0.55 | 0.49 |
| MACD | -0.19 | 0.07 |
| Stochastic Oscillator | 11.96 | 100.00 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.